TherapeuticsMD
TXMD
TXMD
38 hedge funds and large institutions have $5.49M invested in TherapeuticsMD in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
38
Holding in Top 10
–
Calls
$31K
Puts
$7K
Top Buyers
| 1 | +$163K | |
| 2 | +$23.1K | |
| 3 | +$17.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.05K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.1K |
Top Sellers
| 1 | -$59.1K | |
| 2 | -$56.1K | |
| 3 | -$31K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$23.3K |
| 5 |
BlackRock
New York
|
-$17.1K |